09.15.15
According to a recent research report, the global orthopedic trauma devices market was valued at $5.7 billion in 2013 and is expected to grow at a compound annual growth rate (CAGR) of 7.2 percent from 2014 to 2020, to reach an estimated value of $9.4 billion in 2020. Globally, the orthopedic trauma fixation devices market is witnessing a significant growth due to an increase in fractures cases and increasing demand for better facilities in orthopedic trauma surgeries, according to analysts with Persistence Market Research, a New York, N.Y., and India–based market research firm.
Some of the major driving factors for the orthopedic trauma fixation devices market are rising participation in sports and an increase in the elderly population. In addition, government and multinational companies are increasing their investments in the sector, analysts noted. Increased demand for better facilities in trauma surgeries also has set a positive growth rate for the orthopedic trauma fixation device market.
However, various factors such as revision surgeries and absence of health insurance in developing countries, high cost of surgeries and reduced awareness of trauma options compared to other orthopedic sectors are some of the major headwinds faced by the orthopedic trauma fixation device sector. North America is the largest market for orthopedic trauma fixation devices, while the Asia-Pacific region is witnessing the fastest growth. Among the fastest growing markets for orthopedic trauma include China, Japan, India and Southeast Asia.
The Eastern Mediterranean also is experiencing growth, analysts said.
Internal fixators comprise the largest portion of the orthopedic trauma fixation market and is expected to grow at a CAGR of about 6.8 percent during 2014-2020. Plate-and-screw systems are the most frequently used internal fixators for healing a traumatized fracture. The plate-and-screw system market is expected to grow at a CAGR of about 7.1 percent during 2014-2020.
Various companies dealing in orthopedic trauma fixation devices market are increasing their investment in bioabsorbable fixation devices. The bioabsorbable fixation devices market also is experiencing growth, Persistence analysts said. It is expected to grow at a CAGR of about 8.4 percent during 2014-2020, analysts predicted. DePuy Synthes, a Johnson & Johnson company, is the leading player in the global market for orthopedic trauma fixation devices, which had a market share of about 47.3 percent in 2013.
Some of the other companies competing in the orthopedic trauma fixation devices market are Stryker Corp., Zimmer Biomet, Smith & Nephew plc, and Orthofix Holdings Inc.
Some of the major driving factors for the orthopedic trauma fixation devices market are rising participation in sports and an increase in the elderly population. In addition, government and multinational companies are increasing their investments in the sector, analysts noted. Increased demand for better facilities in trauma surgeries also has set a positive growth rate for the orthopedic trauma fixation device market.
However, various factors such as revision surgeries and absence of health insurance in developing countries, high cost of surgeries and reduced awareness of trauma options compared to other orthopedic sectors are some of the major headwinds faced by the orthopedic trauma fixation device sector. North America is the largest market for orthopedic trauma fixation devices, while the Asia-Pacific region is witnessing the fastest growth. Among the fastest growing markets for orthopedic trauma include China, Japan, India and Southeast Asia.
The Eastern Mediterranean also is experiencing growth, analysts said.
Internal fixators comprise the largest portion of the orthopedic trauma fixation market and is expected to grow at a CAGR of about 6.8 percent during 2014-2020. Plate-and-screw systems are the most frequently used internal fixators for healing a traumatized fracture. The plate-and-screw system market is expected to grow at a CAGR of about 7.1 percent during 2014-2020.
Various companies dealing in orthopedic trauma fixation devices market are increasing their investment in bioabsorbable fixation devices. The bioabsorbable fixation devices market also is experiencing growth, Persistence analysts said. It is expected to grow at a CAGR of about 8.4 percent during 2014-2020, analysts predicted. DePuy Synthes, a Johnson & Johnson company, is the leading player in the global market for orthopedic trauma fixation devices, which had a market share of about 47.3 percent in 2013.
Some of the other companies competing in the orthopedic trauma fixation devices market are Stryker Corp., Zimmer Biomet, Smith & Nephew plc, and Orthofix Holdings Inc.